Adriano Arguedas, Medical director

Pfizer

Disclosure(s): Pfizer: Stocks/Bonds

Poster(s):

• 576 - Burden of Pneumococcal Disease Due to Serotypes Covered by the 13-Valent and New Higher-Valent Pneumococcal Conjugate Vaccines in All Children and Children at Risk in the United States
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET